bf/NASDAQ:SABS_icon.jpeg

NASDAQ:SABS

SAB Biotherapeutics, Inc.

  • Stock

USD

Last Close

2.76

26/07 20:00

Market Cap

29.53M

Beta: 1.26

Volume Today

2.99K

Avg: 1.39M

PE Ratio

−10.36

PFCF: 7.38

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
account payables
2.17M
-
7.38M
240.08%
4.46M
39.61%
3.68M
17.48%
945.93K
74.29%
accumulated other comprehensive income loss
26.42K
-
cash and cash equivalents
6.35M
-
12.61M
98.71%
33.21M
163.33%
15.05M
54.69%
56.57M
275.93%
cash and short term investments
6.35M
-
12.61M
98.71%
33.21M
163.33%
15.05M
54.69%
56.57M
275.93%
common stock
3.52K
-
3.52K
0%
4.35K
23.48%
5.09K
17.13%
929
81.76%
deferred revenue
100K
-
100K
0%
1.32M
-
deferred revenue non current
deferrred tax liabilities non current
goodwill
goodwill and intangible assets
intangible assets
inventory
long term debt
5.69M
-
6.47M
13.66%
5.42M
16.28%
4.53M
16.31%
4.05M
10.55%
long term investments
net debt
1.29M
-
-4.48M
447.19%
-26.46M
490.12%
-9.12M
65.54%
-50.66M
455.59%
net receivables
2.82M
-
20.57M
629.74%
8.01M
61.06%
5.56M
30.64%
other assets
other current assets
7.20M
-
1.49M
79.26%
2.34M
56.68%
other current liabilities
500.80K
-
1.92M
283.71%
18.80M
878.14%
9.92M
47.24%
6.69M
32.52%
other liabilities
other non current assets
467.69K
-
350.23K
25.12%
other non current liabilities
10.00M
-
10.72M
-
320.93K
97.01%
11.77M
3,568.79%
othertotal stockholders equity
29.79M
-
50.99M
71.14%
67.67M
32.73%
78.92M
16.62%
147.34M
86.68%
preferred stock
1.44K
-
2.06K
42.83%
5
-
property plant equipment net
8.71M
-
22.08M
153.39%
30.95M
40.15%
28.34M
8.43%
24.68M
12.90%
retained earnings
-32.10M
-
-11.98M
62.67%
-29.13M
143.06%
-47.87M
64.34%
-90.06M
88.14%
short term debt
1.95M
-
1.66M
14.83%
1.33M
19.86%
1.40M
5.10%
1.85M
32.70%
short term investments
tax assets
tax payables
216.25K
-
50K
76.88%
total assets
18.00M
-
56.54M
214.04%
79.37M
40.38%
50.90M
35.86%
83.94M
64.90%
total current assets
9.29M
-
34.46M
270.93%
48.42M
40.53%
22.10M
54.36%
58.91M
166.58%
total current liabilities
4.62M
-
11.06M
139.53%
24.68M
123.14%
14.99M
39.26%
10.81M
27.88%
total debt
7.64M
-
8.13M
6.40%
6.74M
17.01%
5.93M
12.09%
5.91M
0.37%
total investments
total liabilities
20.31M
-
17.53M
13.68%
40.82M
132.85%
19.85M
51.38%
26.64M
34.24%
total liabilities and stockholders equity
18.00M
-
56.54M
214.04%
79.37M
40.38%
50.90M
35.86%
83.94M
64.90%
total non current assets
8.71M
-
22.08M
153.39%
30.95M
40.15%
28.81M
6.92%
25.03M
13.10%
total non current liabilities
15.69M
-
6.47M
58.78%
16.14M
149.46%
4.85M
69.92%
15.83M
226.13%
total stockholders equity
-2.31M
-
39.01M
1,791.90%
38.55M
1.17%
31.06M
19.43%
57.30M
84.49%

All numbers in USD (except ratios and percentages)